Blood pressure care | New York
Baxfendy contains baxdrostat, an aldosterone-synthesis inhibitor approved with other blood-pressure medicines for adults not adequately controlled on other agents. Its August 2026 label is broader than a statement that only formally diagnosed resistant hypertension qualifies.
Baxdrostat reduces aldosterone synthesis. Aldosterone affects sodium and potassium handling. The medicine can raise potassium and lower sodium, so laboratory monitoring is central to safe treatment.
Adults whose blood pressure is inadequately controlled may be considered after confirming measurements, current treatment, kidney function, and electrolytes. Taking several drugs or one high reading does not by itself establish suitability.
Review home readings, adherence, interactions, and secondary causes. The label uses 1 or 2 mg once daily based on clinical factors. The prescriber selects the dose and reviews potassium, sodium, and eGFR before treatment and again after starting or a dose change. Keep other agents unless the clinician changes them.
Bring blood-pressure readings, medicine and supplement labels, kidney function, potassium and sodium results, and pregnancy plans. Ask which laboratory review must occur before the next prescription.
Hyperkalemia and hyponatremia require medical management. Discuss potassium supplements, salt substitutes, and medicines that raise potassium. Emergency symptoms from very high blood pressure should not wait for an outpatient drug evaluation.
Follow the clinician’s electrolyte and kidney testing schedule, including the early review after initiation or titration. Report dizziness, weakness, or other new symptoms. Drug-specific evidence does not establish stock or insurance coverage.
Confirm the exact service, clinician, formulation, appointment, and refill route before booking. The evaluation, tests, medicine, administration, and follow-up may have separate costs and benefits. Ask for current estimates and required records. An FDA-approved drug or a clinic address does not establish pharmacy stock, onsite treatment, coverage, or a prescription. If access changes, contact the treating team before interrupting treatment.
Baxfendy contains baxdrostat, an aldosterone-synthesis inhibitor approved with other blood-pressure medicines for adults not adequately controlled on other agents. Its August 2026 label is broader than a statement that only formally diagnosed resistant hypertension qualifies. Baxdrostat reduces aldosterone synthesis. Aldosterone affects sodium and potassium handling. The medicine can raise potassium and lower sodium, so laboratory monitoring is central to safe treatment.
The August 2026 label is for adults inadequately controlled on other agents, in combination with other antihypertensive drugs. The indication is not restricted to the narrower term “resistant hypertension.” The clinician still confirms suitability and laboratory safety.
Baxfendy needs potassium and kidney-function review before and during treatment according to its label and the patient’s risk. Other medicines and kidney disease can change the monitoring plan. Ask which results are required, when to repeat them and how an abnormal result changes the dose or suitability; testing is broader than asking whether potassium can rise.
Review home readings, adherence, interactions, and secondary causes. The label uses 1 or 2 mg once daily based on clinical factors. The prescriber selects the dose and reviews potassium, sodium, and eGFR before treatment and again after starting or a dose change. Keep other agents unless the clinician changes them. This is label information, not an individualized prescription. The prescriber must set your dose.
Baxfendy can raise potassium and lower sodium. The prescriber reviews potassium, sodium, and eGFR before treatment and after starting or changing the dose. Other medicines and salt substitutes can affect risk. Keep the laboratory schedule and do not adjust treatment yourself.
Baxfendy has a US-approved label, and AstraZeneca announced its approval on May 18, 2026. For a treatment start as of October 9, 2026, ask the dispensing pharmacy whether the prescribed strength can be filled and how ongoing supply will be arranged. Current fill timing needs confirmation with the pharmacy. Continue prescribed blood-pressure treatment until the clinician gives a change plan.
Hyperkalemia and hyponatremia require medical management. Discuss potassium supplements, salt substitutes, and medicines that raise potassium. Emergency symptoms from very high blood pressure should not wait for an outpatient drug evaluation.
The evaluation should confirm reliable blood-pressure measurements, the current regimen, adherence, other causes of poor control, kidney function and electrolyte risk, interacting medicines, and whether the patient needs urgent or specialty care.
Baxfendy is a once-daily oral tablet that can be taken with or without food. It is added to other antihypertensive treatment when the current regimen is not adequate. It does not replace a complete hypertension evaluation.
The label requires serum potassium and sodium assessment before treatment and periodically afterward, with more frequent checks for patients at increased risk. Medicines that raise potassium and CYP3A inducers require special attention.
The evaluation should confirm reliable blood-pressure measurements, the current regimen, adherence, other causes of poor control, kidney function and electrolyte risk, interacting medicines, and whether the patient needs urgent or specialty care.
The label requires serum potassium and sodium assessment before treatment and periodically afterward, with more frequent checks for patients at increased risk. Medicines that raise potassium and CYP3A inducers require special attention.
Before starting Baxfendy, discuss baseline and follow-up blood tests, other medicines, pharmacy supply, cost and when to seek urgent care with your clinician.
An evaluation may lead to another medicine, more testing, a referral, or no medication change.
The health plan and dispensing pharmacy make coverage and fulfillment decisions. Prior authorization may be required.
The clinic cards below show places to start an evaluation. They do not prove that a product is stocked, dispensed, taught, or administered at that site.
Bronx
932 E 174th St, Bronx, NY 10460
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Queens
37-15 23rd Ave, Astoria, NY 11105
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Bronx
2063A Bartow Ave, Bronx, NY 10475
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Long Island
232 W Old Country Rd, Hicksville, NY 11801
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Queens
30-07 36th Ave, Astoria, NY 11106
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Long Island
135 Mineola Blvd, Mineola, NY 11501
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Manhattan
259 1st Ave, New York, NY 10003
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Use ongoing primary care to connect medication decisions with the rest of your health history.
Connect blood-pressure treatment with broader cardiovascular risk reduction.
Coordinate medicines when hypertension and diabetes occur together.
Review possible sleep apnea when symptoms and clinical context support testing.
Address related cardiovascular risk questions without mixing treatment intents.
Content was updated August 1, 2026 using the sources cited above. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.